PMC:7755033 / 32933-33313 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"586","span":{"begin":168,"end":178},"obj":"Chemical"},{"id":"587","span":{"begin":260,"end":270},"obj":"Chemical"},{"id":"596","span":{"begin":344,"end":346},"obj":"Species"}],"attributes":[{"id":"A586","pred":"tao:has_database_id","subj":"586","obj":"MESH:D000069449"},{"id":"A587","pred":"tao:has_database_id","subj":"587","obj":"MESH:C557213"},{"id":"A596","pred":"tao:has_database_id","subj":"596","obj":"Tax:126910"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ikeness filters (Table 3). The selected phytoconstituents showed no violations of Veber, Egan and Muegge filters thereby indicating their drug-like character. The drug cinacalcet showed 1 and 2 violations of Egan and Muegge filters, respectively, whereas drug poziotinib exhibited 1 violation of Muegge filter.\nTable 3. Drug-like character of WS phytoconstituents versus FDA-appr"}

{"project":"LitCovid-sentences","denotations":[{"id":"T314","span":{"begin":27,"end":158},"obj":"Sentence"},{"id":"T315","span":{"begin":159,"end":310},"obj":"Sentence"},{"id":"T316","span":{"begin":311,"end":319},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ikeness filters (Table 3). The selected phytoconstituents showed no violations of Veber, Egan and Muegge filters thereby indicating their drug-like character. The drug cinacalcet showed 1 and 2 violations of Egan and Muegge filters, respectively, whereas drug poziotinib exhibited 1 violation of Muegge filter.\nTable 3. Drug-like character of WS phytoconstituents versus FDA-appr"}